Trial Profile
A Phase II, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Jan 2012
Price :
$35
*
At a glance
- Drugs Tipelukast (Primary)
- Indications Interstitial cystitis
- Focus Therapeutic Use
- Sponsors MediciNova
- 25 Jan 2012 New trial record